Glaxosmithkline Pharmaceuticals Ltd. (GLAXO): Glaxosmithkline Pharmaceuticals Share Price rises 2.77% as stock trades at Rs 3,040.65

Glaxosmithkline Pharmaceuticals Share Price is in focus after the stock rose 2.77% to Rs 3,040.65, adding Rs 82.05 from the previous close of Rs 2,958.60. The company’s market capitalisation now stands at Rs 50,120.47 Cr, keeping Glaxosmithkline Pharmaceuticals Share Price among the notable healthcare names in the Indian stock market today.

According to latest Univest data, the move confirms a clear same-day price rise, but it does not establish a company-specific catalyst. That makes the latest Glaxosmithkline Pharmaceuticals Stock News relevant as a price event first, and as a valuation and sector story second. The stock opened at Rs 2,932.10, touched a high of Rs 3,043.85 and a low of Rs 2,932.10, while turnover stood at Rs 0.4 Cr. Investors tracking Glaxosmithkline Pharmaceuticals Share Price Today can therefore focus on what the move shows about positioning in pharmaceuticals, rather than look for a verified trigger that is not present in the market update. Univest data also helps frame the move against sector benchmarks and listed peers.

Glaxosmithkline Pharmaceuticals Share Price Today: Price Action Analysis

Glaxosmithkline Pharmaceuticals Ltd. (GLAXO) rose to Rs 3,040.65 from the previous close of Rs 2,958.6, a move of Rs 82.05 or 2.77%. The stock opened at Rs 2,932.1, reached a high of Rs 3,043.85, recorded a low of Rs 2,932.1.

Glaxosmithkline Pharmaceuticals Share Price today moved higher by Rs 82.05, or 2.77%, from the previous close of Rs 2,958.60 to Rs 3,040.65. The stock traded between Rs 2,932.10 and Rs 3,043.85, so the intraday range remained relatively contained even as the share price rose. In the context of Stocks Rising Today, this was a clean positive move rather than a broad swing, and Glaxosmithkline Pharmaceuticals Share Price Live shows the stock near the upper end of its range. The latest Univest figures confirm a share price rise, but do not identify a company-specific reason. For readers searching Glaxosmithkline Pharmaceuticals Share Price Update, the core point is simple: price moved up, turnover stayed modest at Rs 0.4 Cr, and the stock remained active in Stocks in News.

Glaxosmithkline Pharmaceuticals Ltd. (GLAXO) Fundamental Analysis

Glaxosmithkline Pharmaceuticals Ltd. (GLAXO) fundamental metrics show P/E 46.92x, P/B 19.89x, ROE 48.76%, ROCE 66.79%. These figures provide context only and are not a buy or sell signal.

Glaxosmithkline Pharmaceuticals Ltd. has a market capitalisation of Rs 50120.47 crore and falls in the Large Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 46.92x, P/B at 19.89x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 48.76% and ROCE of 66.79%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 63.05, book value per share of Rs 148.77, dividend yield of 1.93%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 32.83x, median ROE of 11.78%, median ROCE of 13.65%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.

Sector and Industry Context

Glaxosmithkline Pharmaceuticals Ltd. (GLAXO) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.

Glaxosmithkline Pharmaceuticals Ltd. (GLAXO) has a P/E ratio of 46.92x, which is above the benchmark median of 32.83x, a difference of +42.92%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

Glaxosmithkline Pharmaceuticals Ltd. (GLAXO) has a ROE of 48.76%, which is above the benchmark median of 11.78%, a difference of +313.92%. Glaxosmithkline Pharmaceuticals Ltd. (GLAXO) has a ROCE of 66.79%, which is above the benchmark median of 13.65%, a difference of +389.3%.

Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.

Peer Comparison

Glaxosmithkline Pharmaceuticals Ltd. (GLAXO) has a P/E ratio of 46.92x compared with the displayed peer median of 37.67x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 48.76% compares with a peer median of 16.19% across the companies shown in the table. ROCE stood at 66.79% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Glaxosmithkline Pharmaceuticals Ltd. (GLAXO) has a market capitalisation of Rs 50,120.47 crore. Among the 5 peers shown, 5 have a larger market capitalisation.

Why Investors Are Watching Glaxosmithkline Pharmaceuticals

• Glaxosmithkline Pharmaceuticals Share Price rose 2.77% today, putting it among the market movers in healthcare.
• The stock traded near the top of its intraday range, with Rs 3,043.85 as the high and Rs 2,932.10 as the low.
• Glaxosmithkline Pharmaceuticals Fundamental Analysis highlights high ROE, high ROCE and an elevated valuation profile.
• Sector context shows the company trading above the same-industry median on P/E and well above it on P/B.
• Peer comparison keeps Glaxosmithkline Pharmaceuticals Share Price in focus against larger pharma names and other high-valued stocks.

About Glaxosmithkline Pharmaceuticals Ltd.

Glaxosmithkline Pharmaceuticals Ltd. operates in the Healthcare sector and the Pharmaceuticals & Drugs industry. The company is known for pharmaceutical products and related healthcare offerings, and its listed market position is shaped by its brand, portfolio and return profile. For readers following Glaxosmithkline Pharmaceuticals Share Price, the business context matters because market attention in pharma often reflects both product strength and valuation discipline.

Glaxosmithkline Pharmaceuticals Stock News typically attracts investors who track large-cap healthcare names with strong profitability metrics. In that setting, Glaxosmithkline Pharmaceuticals Share Price Today is being read not only as a one-day price rise, but also as part of a wider market assessment of how the company sits within the pharmaceuticals landscape. The company’s scale, profitability and sector placement all support its relevance in any Glaxosmithkline Pharmaceuticals Stock Analysis.

Frequently Asked Questions

Why is Glaxosmithkline Pharmaceuticals Share Price rising today?

Ans. Glaxosmithkline Pharmaceuticals Share Price rose 2.77% to Rs 3,040.65. The latest Univest data confirms the move, but it does not establish a company-specific catalyst, so the event should be read as verified price action.

What is Glaxosmithkline Pharmaceuticals Share Price today?

Ans. Glaxosmithkline Pharmaceuticals Share Price today is Rs 3,040.65. It is up Rs 82.05 from the previous close of Rs 2,958.60, which places the stock among the stronger healthcare movers.

What is the market capitalisation of Glaxosmithkline Pharmaceuticals?

Ans. Glaxosmithkline Pharmaceuticals has a market capitalisation of Rs 50,120.47 Cr. That scale is well above the same-industry median and helps explain why Glaxosmithkline Pharmaceuticals Share Price attracts regular market attention.

How did Glaxosmithkline Pharmaceuticals trade during the day?

Ans. The stock opened at Rs 2,932.10, touched a high of Rs 3,043.85 and a low of Rs 2,932.10. Glaxosmithkline Pharmaceuticals Share Price therefore moved higher while staying within a contained intraday band.

What do the valuation ratios show for Glaxosmithkline Pharmaceuticals?

Ans. The company’s P/E is 46.92 and P/B is 19.89. Both sit above the same-industry medians, so Glaxosmithkline Pharmaceuticals Share Price is trading at a premium versus many healthcare peers.

How strong are the return ratios for Glaxosmithkline Pharmaceuticals?

Ans. ROE stands at 48.76 and ROCE at 66.79. Those figures are well above the industry benchmark, which supports the quality narrative around Glaxosmithkline Pharmaceuticals Share Price in current market analysis.

What do EPS, book value and dividend yield mean here?

Ans. EPS is Rs 63.05, book value is Rs 148.77 and dividend yield is 1.93%. Together they give a clearer picture of earnings, accounting value and payout context behind Glaxosmithkline Pharmaceuticals Share Price.

How does Glaxosmithkline Pharmaceuticals compare with pharma peers?

Ans. Glaxosmithkline Pharmaceuticals Share Price sits below Sun Pharma and Divi's on market cap, but its P/B and return ratios are stronger than several listed peers. That makes it a distinct name in the healthcare pack.

Track Glaxosmithkline Pharmaceuticals Share Price on Univest

Use Glaxosmithkline Pharmaceuticals Ltd. (GLAXO) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top-gainers lists and related market analysis.

Users can track Glaxosmithkline Pharmaceuticals Share Price on Univest for live price updates, valuation ratios, company financials, sector comparisons and market insights. The platform also helps readers review Glaxosmithkline Pharmaceuticals Latest News, Glaxosmithkline Pharmaceuticals Share Price Live, 52-week levels and broader market context in one place. For investors comparing Glaxosmithkline Pharmaceuticals Share Price Today with peers, Univest keeps the data organised and easy to follow.